Aberdeen Asset Management PLC UK lowered its position in shares of PerkinElmer, Inc. (NYSE:PKI) by 15.5% during the first quarter, Holdings Channel reports. The institutional investor owned 23,428 shares of the medical research company’s stock after selling 4,303 shares during the period. Aberdeen Asset Management PLC UK’s holdings in PerkinElmer were worth $1,360,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in PKI. Janus Capital Management LLC boosted its position in shares of PerkinElmer by 9.0% in the fourth quarter. Janus Capital Management LLC now owns 7,135,509 shares of the medical research company’s stock worth $372,117,000 after buying an additional 587,948 shares in the last quarter. State Street Corp boosted its position in shares of PerkinElmer by 6.8% in the fourth quarter. State Street Corp now owns 3,792,638 shares of the medical research company’s stock worth $197,792,000 after buying an additional 241,465 shares in the last quarter. Pictet Asset Management Ltd. boosted its position in shares of PerkinElmer by 14.9% in the first quarter. Pictet Asset Management Ltd. now owns 3,362,119 shares of the medical research company’s stock worth $195,204,000 after buying an additional 435,836 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of PerkinElmer by 2.7% in the first quarter. Bank of New York Mellon Corp now owns 1,049,537 shares of the medical research company’s stock worth $60,937,000 after buying an additional 27,484 shares in the last quarter. Finally, Levin Capital Strategies L.P. boosted its position in shares of PerkinElmer by 61.9% in the first quarter. Levin Capital Strategies L.P. now owns 980,463 shares of the medical research company’s stock worth $56,926,000 after buying an additional 374,761 shares in the last quarter. 89.82% of the stock is currently owned by institutional investors.
PerkinElmer, Inc. (PKI) traded up 1.39% during trading on Friday, reaching $64.87. The company had a trading volume of 410,830 shares. The firm’s 50 day moving average is $61.01 and its 200 day moving average is $55.78. PerkinElmer, Inc. has a one year low of $45.35 and a one year high of $64.95. The company has a market capitalization of $7.14 billion, a PE ratio of 31.63 and a beta of 0.80.
PerkinElmer (NYSE:PKI) last issued its quarterly earnings data on Thursday, May 4th. The medical research company reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.01. PerkinElmer had a return on equity of 14.26% and a net margin of 10.52%. The business had revenue of $514.12 million for the quarter, compared to the consensus estimate of $506.81 million. During the same period in the prior year, the business posted $0.50 earnings per share. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. On average, equities research analysts predict that PerkinElmer, Inc. will post $2.86 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 10th. Shareholders of record on Friday, July 21st will be given a dividend of $0.07 per share. The ex-dividend date is Wednesday, July 19th. This represents a $0.28 dividend on an annualized basis and a yield of 0.43%. PerkinElmer’s dividend payout ratio (DPR) is presently 13.15%.
TRADEMARK VIOLATION NOTICE: “Aberdeen Asset Management PLC UK Has $1.36 Million Stake in PerkinElmer, Inc. (PKI)” was originally reported by Mideast Time and is the property of of Mideast Time. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.mideasttime.com/aberdeen-asset-management-plc-uk-has-1-36-million-stake-in-perkinelmer-inc-pki/1750374.html.
PKI has been the topic of a number of research reports. Barclays PLC set a $55.00 price objective on PerkinElmer and gave the company a “sell” rating in a report on Saturday, May 6th. Cantor Fitzgerald reissued a “hold” rating and set a $65.00 price objective on shares of PerkinElmer in a report on Friday, May 5th. Zacks Investment Research raised PerkinElmer from a “sell” rating to a “hold” rating in a report on Friday, March 10th. Jefferies Group LLC reissued a “hold” rating and set a $49.00 price objective on shares of PerkinElmer in a report on Friday, May 5th. Finally, Janney Montgomery Scott raised PerkinElmer from a “neutral” rating to a “buy” rating in a report on Monday, March 27th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $57.30.
In other PerkinElmer news, insider Andrew Okun sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, March 20th. The stock was sold at an average price of $57.27, for a total transaction of $171,810.00. Following the sale, the insider now directly owns 12,441 shares in the company, valued at $712,496.07. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Peter Barrett sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $63.22, for a total value of $632,200.00. Following the sale, the director now owns 29,200 shares in the company, valued at $1,846,024. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 200,275 shares of company stock worth $11,931,678. Company insiders own 2.30% of the company’s stock.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.